ArticleJournal of the American Heart Association2025
Comparing the "Life's Essential 8" Scores of Older Adults Living With Cardiovascular Diseases: NHANES, 2013 to 2018.
Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Temporal Trends in Cardiovascular Health Metrics in Italy, 2015-2024: A Ten-Year Report from the Longevity Check-Up (Lookup) 8+ Study.Medical sciences (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe American Heart Association's Life's Essential 8 (LE8) framework quantifies cardiovascular health. Prior studies have focused on individuals without clinical cardiovascular disease (CVD). We sought to examine recent trends in LE8 scores among older adults with prevalent CVD.
methodsWe included noninstitutionalized older US adults (ages 65+) from NHANES (National Health and Nutrition Examination Survey 2013-18). Overall LE8 scores (range 0-100; higher is better cardiovascular health) were calculated for all participants. CVD diagnoses were self-reported, including coronary heart disease, stroke, heart failure, hypertension, angina, and myocardial infarction. Percent change in LE8 scores from 2013 to 2018 was calculated for each diagnosis group, and a linear regression tested for significance of changes within groups.
resultsThe 3050 participants represented 37 908 305 US adults (54.7% women; mean age 72.6). LE8 scores tended to stay stable or decline between 2013 to 2014 and 2017 to 2018 for those with and without CVD. Significant decreases in mean LE8 scores occurred in those with hypertension, with a 4.1% decline (from 59.6 to 57.1 [
conclusionsLE8 scores remained stable or declined for older US adults before the COVID-19 pandemic. Populations with hypertension, stroke, and heart failure had significant LE8 score declines. Because LE8 metrics include behavioral and physiologic metrics associated with CVD risk, these data indicate concerning trends and primary and secondary prevention opportunities in older US adults, who are at highest risk for incident and recurrent CVD events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.